Eikon Therapeutics share price logo

Eikon Therapeutics Share Price

NASDAQ: EIKN

Small Cap

$11.02

-0.69

(-5.89%)

as on

Eikon Therapeutics Stock Performance

as on March 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $10.90
    $11.78
    downward going graph

    1.09%

    Downside

    6.90%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Eikon Therapeutics share price movements today

Previous Close
$11.71
Open
$11.78
Volume
586.9K
Day's Low - High
$10.90 - $11.78

Eikon Therapeutics Historical Returns

1 Month Return
-21.36 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Eikon Therapeutics Stock Fundamentals & Key Indicators

Check Eikon Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$638.1M

EPS (TTM)

-55.8925

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

Eikon Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Eikon Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Eikon Therapeutics image
Eikon Therapeutics
NA$638.1MNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B126.75%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.49%29.6832.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA1115.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B58.91%17.6731.41%

Eikon Therapeutics Stock’s Investor Sentiment and Interest

Search interest for Eikon Therapeutics Stock has increased by 850% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:850% versus previous 30 day period

Eikon Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Dec 2024
Total Revenue
-
Gross Profit
-
Operating Income
-67
EBITDA
-
Interest Expense
0
Depreciation
6
Income Before Tax
-64
Income Tax Expense
-
Net Income
-64
Net Profit Margin
0.00%

Eikon Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2023
Dec 2024
Total Revenue
-
-
Gross Profit
-
-
Operating Income
-265
-260
EBITDA
-
-
Interest Expense
0
0
Depreciation
17
25
Income Before Tax
-241
-243
Income Tax Expense
-
-
Net Income
-241
-243
Net Profit Margin
0.00%
0.00%

Eikon Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2024
Net Income
-243
Operating Cash Flow
-134
Investing Cash Flow
-
Financing Cash Flow
0
Change in Cash
16

Insights on Eikon Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, EIKN stock has moved down by -21.4%

About Eikon Therapeutics

Eikon Therapeutics, Inc. is a late-stage clinical biopharmaceutical company, which is focused on advancing a pipeline of potential therapies for patients with unmet medical needs. The Company has clinical programs at various stages of development, and active discovery efforts in oncology and neurological disease. Its pipeline includes EIK1001 TLR7/8 Melanoma, EIK1001 TLR7/8 NSCLC, EIK1003 PARP1, EIK1004 PARP1, EIK1005 WRN Phase 1, EIK1006, and AR-V7. EIK1001 is a systemically administered dual-agonist of toll-like receptors 7 and 8 that has demonstrated single-agent activity, as well as activity in combination with anti-PD-(L)1 agents, across multiple solid tumor types in Phase 1 trials. EIK1003 targets PARP1, a central component of DNA repair machinery in normal cells. EIK1003 is being evaluated in a Phase 1/2 study of patients with breast, ovarian, or prostate malignancies that have known or suspected deleterious mutations of select homologous recombination repair (HRR) genes.
OrganisationEikon Therapeutics
Headquarters230 Harriet Tubman Way, Millbrae, CA, United States, 94030
CEODr. Roger M. Perlmutter M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Eikon Therapeutics

Name

Title

Dr. Roger M. Perlmutter M.D., Ph.D.

Chairman, President & CEO

Mr. Michael A. Klobuchar

Chief Operating Officer

Dr. Eric Betzig Ph.D.

Co-Founder & Member of Scientific Advisory Board

Mr. Benjamin Bruno Thorner

Secretary, General Counsel & Chief Business Officer

Dr. Roy D. Baynes FACP, M.D., Ph.D.

Executive VP & Chief Medical Officer

Dr. Robert Tjian Ph.D.

Co-Founder & Member of Scientific Advisory Board

Dr. Alfred Lloyd Bowie Jr., Ph.D.

Treasurer & CFO

Mr. Russ Berman

Chief Technology Officer

Ms. Barbara Howes M.B.A.

Chief People Officer

FAQs

What is Eikon Therapeutics share price today?

Eikon Therapeutics share price today is $11.02 as on at the close of the market. Eikon Therapeutics share today touched a day high of $11.78 and a low of $10.9.

What is the 52 week high and 52 week low for Eikon Therapeutics share?

Eikon Therapeutics share touched a 52 week high of $ on and a 52 week low of $ on . Eikon Therapeutics stock price today i.e. is closed at $11.02,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Eikon Therapeutics's market capitalisation today?

Eikon Therapeutics market capitalisation is $0.00T as on .

How to invest in Eikon Therapeutics Stock (EIKN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Eikon Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Eikon Therapeutics Shares that will get you 0.1361 shares as per Eikon Therapeutics share price of $11.02 per share as on March 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Eikon Therapeutics Stock (EIKN) from India?

Indian investors can start investing in Eikon Therapeutics (EIKN) shares with as little as ₹93.734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Eikon Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Eikon Therapeutics share’s latest price of $11.02 as on March 25, 2026 at 1:29 am IST, you will get 0.9074 shares of Eikon Therapeutics. Learn more about fractional shares .